TriangleUltra Low Dose 4 Gy Radiation (NCT05929612)
Ultra Low Dose 4 Gy Radiation trial for Lymphoma (NCT05929612). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with stage I–II marginal-zone lymphoma. Prior treatment is allowed; residual-disease requirements vary by setting. Systemic therapy must not be planned before the first post-radiation assessment; gastric MALT lymphoma requires Helicobacter pylori testing.
The idea: researchers test whether radiation can control lymphoma using less treatment. Patients receive four gray in two treatments over one–two days. Response determines whether twelve additional gray are needed. Researchers assess response, recurrence, survival, and toxicity.
This phase 2 study plans 50 patients. Jillian Gunther leads at MD Anderson, Houston, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.